Testing blood pressure pills with two or three medicines
Part of Heart & circulation clinical trials.
This trial studies whether fixed-dose blood pressure medicines—either two drugs (fimasartan + amlodipine) or three drugs (fimasartan + amlodipine + hydrochlorothiazide)—work well and are safe. It may help your care team compare how these combinations control blood pressure and what side effects occur.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are willing to sign the informed consent form and understand the study
- You are age 19 or older (male or female)
- You have been diagnosed with essential (primary) high blood pressure and plan to use one of these combinations: fimasartan/amlodipine or fimasartan/amlodipine/hydrochlorothiazide
- Your blood pressure or treatment history fits one of the study’s high-blood-pressure categories (for example, stage 2/high-risk, or still above goal even with prior treatment)
- You can stay in the study until the end and will work with study visits and instructions
- You do not have conditions suggesting a secondary cause of high blood pressure
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of two new medications (AD-227A and AD-227B) to see if they work better together for people with essential (common) high blood pressure. It could be a new treatment option to help control your blood pressure.
This study tests whether taking two separate blood pressure medications work as well as taking them combined in one pill for people with high blood pressure and type 2 diabetes. The goal is to find the best, safest way to treat both conditions together.
This trial tests five new medications to see how well they lower blood pressure in people with essential hypertension (high blood pressure with no known cause). Participants will temporarily stop their current blood pressure medicine during the study.
This study tests a new combination of three medications (THP-00101, THP-00102, and THP-00103) for people with type 2 diabetes and essential high blood pressure. It aims to see if this combination is safe and effective compared to standard treatments.
This study tests a new combination blood pressure medicine (HCP1803-4) for people with essential hypertension. It aims to see if the medicine works better than current options and is safe for long-term use.
This trial tests whether taking two experimental drugs together can safely lower both high blood pressure and high cholesterol. It may be an option if you have both conditions and your blood pressure is not extremely high.
Hear when a new Hypertension,Essential trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.